Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve‐Month, Randomized, Double‐Blind Study

Objective To compare the efficacy and safety of intravenous (IV) abatacept, a selective T cell costimulation modulator, versus placebo for the treatment of active class III or IV lupus nephritis, when used on a background of mycophenolate mofetil and glucocorticoids. Methods This was a 12‐month, ran...

Celý popis

Podrobná bibliografia

Vydané v:	Arthritis & rheumatology (Hoboken, N.J.) Ročník 66; číslo 2; s. 379 - 389
Hlavní autori:	Furie, Richard, Nicholls, Kathy, Cheng, Tien‐Tsai, Houssiau, Frederic, Burgos‐Vargas, Ruben, Chen, Shun‐Le, Hillson, Jan L., Meadows‐Shropshire, Stephanie, Kinaszczuk, Michael, Merrill, Joan T.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Wiley Subscription Services, Inc 01.02.2014
Predmet:	Abatacept Adult Dose-Response Relationship, Drug Double-Blind Method Female Humans Immunoconjugates - therapeutic use Immunosuppressive Agents - therapeutic use Internationality Longitudinal Studies Lupus Lupus Nephritis - drug therapy Male Severity of Illness Index Treatment Outcome
ISSN:	2326-5191, 2326-5205, 2326-5205
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!